Relacore Deep Sleep
Natural health product licensed in Canada
- Licence holder
- The Carter-Reed Company, LLC
- NPN or DIN-HM
- 80077452
- Status
- Inactive licence
- Licence date
- 12 May 2017
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 999.9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 9.99 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Oxyde de zinc | 3.33 milligramme | 9,990 µg |
| Folate Source : Acide folique | 133.33 microgrammes | Not calculated |
| Humulus lupulus Source : Strobiles | 1.67 milligramme | Not calculated |
| Matricaria chamomilla Source : Fleur | 1.67 milligramme | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1 milligramme | Not calculated |
| Riboflavine Source : Riboflavine | 5 milligramme | 15,000 µg |
| Vitamine B12 Source : Cyanocobalamine | 3.33 microgrammes | Not calculated |
| Calcium Source : Carbonate de calcium | 33.3 milligramme | 99,900 µg |
| Magnésium Source : Oxyde de magnésium | 33.3 milligramme | 99,900 µg |
| Niacinamide Source : Niacinamide | 16.67 milligramme | Not calculated |
| Valeriana officinalis Source : Racine | 1.67 milligramme | Not calculated |
| Vitamine C Source : Acide ascorbique | 333.3 milligramme | 999,900 µg |
| Thiamine Source : Chlorhydrate de thiamine | 5 milligramme | 15,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 3.33 milligramme | 9,990 µg |
| Biotine Source : Biotine | 50 microgrammes | Not calculated |
| Acide pantothénique Source : D-Pantothénate de calcium | 7.67 milligramme | 23,010 µg |
| L-théanine Source : L-Théanine | 66.67 milligramme | Not calculated |
Non-medicinal ingredients
Poly(alcool vinylique), Croscarmellose de sodium, Microcrystalline cellulose, Stéarate de magnésium, Poly(éthylène glycol), Talc, Silice, Laque bleu 1, Acide stéarique, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce symptoms of stress and mild anxiety, which may aggravate sleeplessness. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder syndrome. Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to temporarily promote relaxation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80077452
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.